Related Experiment Video
Updated: May 12, 2026
15:04
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Combining cancer immunotherapy and targeted therapy
1Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, United States. aribas@mednet.ucla.edu
Current Opinion in Immunology
|April 9, 2013
Summary
Targeted therapies can enhance cancer immunotherapy by blocking tumor growth pathways without harming immune cells. Combining these agents with immunotherapies may improve tumor regression and durable responses.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Tumor growth and progression are driven by specific signaling pathways.
- Current tumor immunotherapies show promise but can be enhanced for greater efficacy.
- Targeting oncogenic pathways offers a strategy to improve antitumor responses.
Purpose of the Study:
- To explore the potential of pharmacologically modulating tumor-driving signaling pathways.
- To investigate combinatorial approaches combining targeted agents with tumor immunotherapies.
- To assess the impact on lymphocyte function and antitumor activity.
Main Methods:
- Utilizing novel targeted agents to specifically block oncogenic events in cancer cells.
- Modulating key signaling pathways in both cancer cells and lymphocytes.
- Evaluating the combined effects of targeted agents and tumor immunotherapies.
Main Results:
- Targeted agents can induce a pro-apoptotic environment in cancer cells.
- This may increase cancer cell sensitivity to cytotoxic T lymphocytes (CTLs).
- Pathway modulation in lymphocytes might yield activating effects, enhancing antitumor immunity.
Conclusions:
- Combinatorial strategies merging targeted therapy and immunotherapy can improve tumor regression frequency.
- This approach aims to combine the specificity of small molecule inhibitors with the durability of immunotherapy.
- Pharmacological modulation offers a rational design for enhanced cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...